Abiochem Biotechnology is a high-tech enterprise founded in 2015, specializing in enzyme engineering and genetic engineering technologies. The company focuses on the development of biocatalytic and synthetic biology methods for large-scale production. Its innovations have applications in medicine, health care products, pesticides, and contribute significantly to the advancement of green chemistry. With its recent CNY300.00M Series C investment on 03 May 2021, the company attracted funding from Temasek Holdings and CMB International Capital Corporation. Abiochem's operations span across agriculture, biotechnology, healthcare, and AgriTech industries.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series C | CNY300.00M | 2 |
|
03 May 2021 |
| Series A | Unknown | 4 |
|
28 Nov 2020 |
| Series A | Unknown | 3 |
|
03 Apr 2019 |
No recent news or press coverage available for Abiochem Biotechnology.
We care about your data, and we'd love to use cookies make your experience better.
